| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000273065.1 |
Thapsigargin |
Bladder urothelial carcinoma |
0.022553033 |
Resistant |
| ENSG00000273065.1 |
Thapsigargin |
Esophageal cancer |
0.026853387 |
Resistant |
| ENSG00000273065.1 |
Thapsigargin |
Breast invasive carcinoma |
0.028761728 |
Sensitive |
| ENSG00000273065.1 |
Thapsigargin |
Lung squamous cell carcinoma |
0.009498166 |
Sensitive |
